Browsing Institutt for helse og samfunn by Author "Retterstøl, Kjetil"

Now showing items 1-2 of 2

  • Are PCSK9 Inhibitors Cost Effective? 
    Korman, Max; Retterstøl, Kjetil; Kristiansen, Ivar Sønbø; Wisløff, Torbjørn (Journal article / Tidsskriftartikkel / AcceptedVersion; Peer reviewed, 2018)
    The objective of this study was to review available health economic evaluations of PCSK9 (proprotein convertase subtilisin/kexin type 9) inhibitors. These drugs reduce low-density lipid cholesterol levels and cardiovascular ...
  • Economic evaluation of lipid lowering with PCSK9 inhibitors in patients with familial hypercholesterolemia: Methodological aspects 
    Wisløff, Torbjørn; Mundal, Liv; Retterstøl, Kjetil; Igland, Jannicke; Kristiansen, Ivar Sønbø (Journal article / Tidsskriftartikkel / AcceptedVersion; Peer reviewed, 2019)
    Background and aims Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors have proved to reduce low density lipoprotein cholesterol levels in numerous clinical trials. In two large clinical trials, PCSK9 ...